The Defense Logistics Agency is planning a national requirements contract for seven dosage strengths of Lisdexamfetamine Dimesylate Capsules in 90-count and 100-count bottles. The contract will be firm-fixed price with a one-year base period and four one-year option periods. It will establish a national supply source for the Department of Defense, Indian Health Service, and Department of Veterans Affairs. The projected solicitation date is March 2026, though the agency reserves the right to issue it before or after that date. The acquisition is unrestricted and fully competitive, and the solicitation will be posted to the DLA Bid Board System and SAM.gov.